HAO

Haoxi Health Technology Limited (HAO) Risks & Opportunities Analysis (2026)

Invetso Score: 6.1/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 5.8 (Moderate)

Net debt to EBITDA of 4.3x and negative interest coverage imply refinancing sensitivity, leaving HAO more exposed than peers with lower leverage and positive coverage.

A current ratio of 3.5x supports near-term liquidity, but the weak earnings buffer means peers with stronger cash generation can absorb demand softness more easily.

A very low debt-to-equity ratio suggests limited balance-sheet strain, yet the negative coverage metric indicates operating earnings are still insufficient versus better-capitalized peers.

The short cash conversion cycle reduces working-capital drag, but peers with similarly efficient cycles and stronger margins are better positioned to withstand margin compression.

Opportunities

Score:

A current ratio of 3.5x provides liquidity flexibility, giving HAO more room than leveraged peers to fund inventory, receivables, or short-term growth needs.

The near-zero cash conversion cycle supports faster cash recycling than peers with longer working-capital cycles, improving resilience if demand remains steady.

Low debt-to-equity can preserve strategic optionality versus more levered peers, potentially allowing HAO to navigate cyclical volatility with less equity dilution risk.

Efficient receivables collection and minimal inventory build suggest operating discipline that can translate into better cash preservation than peers in tighter credit conditions.

Overall Score

Score:

HAO’s liquidity and working-capital efficiency provide some peer-relative resilience, but high net leverage and negative interest coverage materially constrain forward positioning versus stronger peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Haoxi Health Technology Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →